Functional Neurological Disorder (FND) Study
- Study HIC#:2000036038
- Last Updated:03/13/2025
A multi-site feasibility clinical trial of Retraining and Control Therapy (ReACT), a mind and body treatment for pediatric functional seizures: The purpose of this study is to assess the feasibility of conducting a future fully powered multi-site efficacy randomized controlled trial (RCT) comparing two treatments for pediatric functional seizures (FS). In this study, 11-18-year-olds diagnosed with FS will be randomized to 12 sessions of Retraining and Control Therapy (ReACT) or Competent Adulthood Transition with Cognitive Behavioral, Humanistic, and Interpersonal Training (CATCH-IT).
https://medicine.yale.edu/childstudy/research/clinical-innovations/fnd-study/
- Age11 years - 18 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
fndstudy@yale.edu
- Phone Number: 1-203-479-0316
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Eligibility Criteria
Inclusion Criteria: Participants must meet all inclusion criteria below to participate in this study.
• Individuals ages 11-18
• EEG-Confirmed functional seizure (FS, PNES, PNEA) diagnosis
• Internet access for sessions
• Parent/guardian willing to participate in the study with the participant
Exclusion Criteria: Participants reporting any of the exclusion criteria cannot participate in this study.
• Comorbid epilepsy
• Less than 4 FS per month
• Other paroxysmal nonepileptic events (e.g. hypoxemic-ischemic phenomena or migraine-associated disorders)
• Concurrent participation in other mental health therapy: This is consistent with clinical practice, in which it is not recommended to be participating in more than one mental health treatment at a time.
• Severe intellectual disability
• Severe mental illness (e.g., schizophrenia, other psychotic diagnosis).
